Company profile: Pyxant Labs
1.1 - Company Overview
Company description
- Provider of GLP bioanalytical chemistry services as a contract research laboratory for life sciences clients, offering bioanalytical method development (validation and optimization), analytical and bioanalytical support for ADME and PK/PD studies, and spatial bioanalysis and spatial biology solutions from discovery through clinical development and NDA approval.
Products and services
- Spatial Biology Solutions: Supplies research-grade spatial biology systems assisting progression from discovery through clinical development to NDA approval for life sciences clients
- Bioanalysis Lab: Delivers GLP-compliant bioanalytical chemistry, including pictogram-level method development with validation and optimization and support for ADME and PK/PD studies to NDA approval
- Spatial Bioanalysis: Offers laboratory-grade spatial bioanalysis products supporting development and approval of life sciences products for programs progressing from discovery toward clinical development.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pyxant Labs
IDEA Pharma
HQ: United States
Website
- Description: Provider of strategic marketing, portfolio and disease area strategy, positioning, scenario planning and communication strategy for pharmaceutical companies, including path-to-market strategies addressing clinical, regulatory and commercial challenges; innovation strategy; strategic pharmaceutical positioning; Immersion, Design, Evaluation, Acceleration insights; and the annual Pharmaceutical Innovation and Invention Index.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEA Pharma company profile →
Optivia
HQ: United States
Website
- Description: Provider of contract research services for the pharmaceutical industry, advancing the utility of transporter research across pharmacokinetics, toxicology, therapeutic target discovery, and basic biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optivia company profile →
Selcia
HQ: United States
Website
- Description: Provider of integrated drug discovery services and high quality 14C radiolabelled compounds to pharma, biotechnology companies and academia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Selcia company profile →
Reverba
HQ: United States
Website
- Description: Provider of patient engagement solutions for pharmaceutical and biotechnology companies, including clinical patient engagement programs powered by the reverbaBRIDGE platform, global clinical trial optimization with patient-centered approaches and real-time data insights, expert recruitment, tech-enabled relationship management and automation, and total compliance with HIPAA, GDPR, and FDA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reverba company profile →
Molecular Neuroimaging
HQ: United States
Website
- Description: Provider of neuroimaging services as a biotechnology firm.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Neuroimaging company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pyxant Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pyxant Labs
2.2 - Growth funds investing in similar companies to Pyxant Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pyxant Labs
4.2 - Public trading comparable groups for Pyxant Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →